Malignant carotid body tumors: What we know, what we do, and what we need to achieve. A systematic review of the literature.
carotid body tumor
malignant
metastasis
surgery
systematic review
Journal
Head & neck
ISSN: 1097-0347
Titre abrégé: Head Neck
Pays: United States
ID NLM: 8902541
Informations de publication
Date de publication:
05 Jan 2024
05 Jan 2024
Historique:
revised:
10
12
2023
received:
04
11
2023
accepted:
20
12
2023
medline:
5
1
2024
pubmed:
5
1
2024
entrez:
5
1
2024
Statut:
aheadofprint
Résumé
Malignant carotid body tumors (MCBT) are rare and diagnosed after detection of nodal or distant metastases. This systematic review (SR) focuses on MCBT initially approached by surgery. Preferred Reporting Items for SR and Meta-Analysis (MA) guided the articles search from 2000 to 2023 on PubMed, Scopus, and Web of Science. Among 3548 papers, 132 (337 patients) were considered for SR; of these, 20 (158 patients) for MA. Malignancy rate was 7.3%, succinate dehydrogenase (SDH) mutation 17%, age at diagnosis between 4th and 6th decades, with a higher prevalence of females. MCBTs were mostly Shamblin III, with nodal and distant metastasis in 79.7% and 44.7%, respectively. Malignancy should be suspected if CBT >4 cm, Shamblin III, painful or otherwise symptomatic, at the extremes of age, bilateral, with multifocal disease, and SDHx mutations. Levels II-III clearance should be performed to exclude nodal metastases and adjuvant treatments considered on a case-by-case basis.
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© 2024 The Authors. Head & Neck published by Wiley Periodicals LLC.
Références
Clairmont AA. Carotid body tumor: a review. Ear Nose Throat J. 1977;56:380-384.
Pellitteri PK, Rinaldo A, Myssiorek D, et al. Paragangliomas of the head and neck. Oral Oncol. 2004;40:563-575.
Sajid MS, Hamilton G, Baker DM, Joint Vascular Research Group. A multicenter review of carotid body tumour management. Eur J Vasc Endovasc Surg. 2007;34:127-130.
Suarez C, Rodrigo JP, Mendenhall WM, et al. Carotid body paragangliomas: a systematic study on management with surgery and radiotherapy. Eur Arch Otorhinolaryngol. 2014;271:23-34.
Williams MD, Tischler AS. Update from the 4th edition of the World Health Organization classification of head and neck tumours: paragangliomas. Head Neck Pathol. 2017;11:88-95.
Jansen JC, van den Berg R, Kuiper A, van der Mey AG, Zwinderman AH, Cornelisse CJ. Estimation of growth rate in patients with head and neck paragangliomas influences the treatment proposal. Cancer. 2000;88:2811-2816.
Gonzalez-Urquijo M, Hinojosa-Gonzalez DE, Fabiani MA, et al. High altitude carotid body tumors growth during active surveillance. Vasc Endovascular Surg. 2023;57:451-455.
Shamblin WR, ReMine WH, Sheps SG, Harrison EG Jr. Carotid body tumor (chemodectoma): clinicopathologic analysis of ninety cases. Am J Surg. 1971;122:732-739.
Mehanna H, Mistry P, Golusinski P, et al. Development and validation of an improved classification and risk stratification system for carotid body tumors: multinational collaborative cohort study. Head Neck. 2021;43:3448-3458.
Robertson V, Poli F, Hobson B, Saratzis A, Naylor AR. A systematic review and meta-analysis of the presentation and surgical management of patients with carotid body tumours. Eur J Vasc Endovasc Surg. 2019;57:477-486.
Li Y, Lin B, Liang S, et al. Epidemiology and survival of patients with malignant carotid body tumors in the SEER database. J Vasc Surg. 2022;76:973-978.
Neumann HPH, Erlic Z, Boedeker CC, et al. Clinical predictors for germ line mutations in head and neck paraganglioma patients: cost reduction strategy in genetic diagnostic process as fall-out. Cancer Res. 2009;69:3650-3656.
Pasini B, Stratakis CA. SDH mutations in tumorigenesis and inherited endoscrine tumors: lesson from the phaeochromocytoma-paraganglioma syndromes. J Intern Med. 2009;266:19-42.
Timmers HJ, Gimenez-Roqueplo AP, Mannelli M, Pacak K. Clinical aspects of SDHx-related pheochromocytoma and paraganglioma. Endocr Relat Cancer. 2009;16:391-400.
Hu K, Persky MS. Treatment of head and neck paragangliomas. Cancer Control. 2016;23:228-241.
Moher D, Liberati A, Tetzlaff J, Altman DG, PRISMA Group. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med. 2009;151:264-269.
Centre for Reviews and Dissemination. Systematic Reviews: CDR's Guidance for Undertaking Reviews in Health Care. University of York; 2006.
Boedeker CC, Neumann HPH, Maier W, Bausch B, Schipper J, Ridder GJ. Malignant head and neck paragangliomas in SDHB mutation carriers. Otolaryngol Head Neck Surg. 2007;137:126-129.
Zhang WC, Cheng JP, Li Q, Zhang L, Wang XD, Anniko M. Clinical and pathological analysis of malignant carotid body tumour: a report of nine cases. Acta Otolaryngol. 2009;129:1320-1325.
Moskovic DJ, Smolarz JR, Stanley D, et al. Malignant head and neck paragangliomas: is there an optimal treatment strategy? Head Neck Oncol. 2010;2:23.
Kruger AJ, Walker PJ, Foster WJ, Jenkins JS, Boyne NS, Jenkins J. Important observations made managing carotid body tumors during a 25-year experience. J Vasc Surg. 2010;52:1518-1524.
Chapman DB, Lippert D, Geer CP, et al. Clinical, histopathologic, and radiographic indicators of malignancy in head and neck paragangliomas. Otolaryngol Head Neck Surg. 2010;143:531-537.
Lian LS, Liu CW, Guan H, Zheng YH, Chen XM, Li YJ. Efficacy of surgical therapy for carotid body tumors. Chin Med Sci J. 2011;26:241-245.
Power AH, Bower TC, Kasperbauer J, et al. Impact of preoperative embolization on outcomes of carotid body tumor resections. J Vasc Surg. 2012;56:979-989.
Papaspyrou K, Mewes T, Rossmann H, et al. Head and neck paragangliomas: report of 175 patients (1989-2010). Head Neck. 2012;34:632-637.
Papaspyrou K, Mann WJ, Amedee RG. Management of head and neck paragangliomas: review of 120 patients. Head Neck. 2009;31:381-387.
Ellis RJ, Patel D, Prodanov T, Nilubol N, Pacak K, Kebebew E. The presence of SDHB mutations should modify surgical indications for carotid body paragangliomas. Ann Surg. 2014;260:158-162.
Mediouni A, Ammari S, Wassef M, et al. Malignant head/neck paragangliomas. Comparative study. Eur Ann Otorhinolaryngol Head Neck Dis. 2014;131:159-166.
Pacheco-Ojeda LA. Carotid body tumors: surgical experience in 215 cases. J Craniomaxillofac Surg. 2017;45:1472-1477.
Pacheco-Ojeda L. Malignant carotid body tumors: report of three cases. Ann Otol Rhinol Laryngol. 2001;110:36-40.
Ikeda A, Shiga K, Katagiri K, et al. Multi-institutional survey of carotid body tumors in Japan. Oncol Lett. 2018;15:5318-5324.
Jiang X, Fang G, Guo D, et al. Surgical management of carotid body tumor and risk factors of postoperative cranial nerve injury. World J Surg. 2020;44:4254-4260.
Gu G, Wang Y, Liu B, et al. Distinct features of malignant carotid body tumors and surgical techniques for challengeable lesions: a case series of 11 patients. Eur Arch Otorhinolaryngol. 2020;277:853-861.
Valero C, Ganly I, Shah JP. Head and neck paragangliomas: 30-year experience. Head Neck. 2020;42:2486-2495.
Fathalla AE, Elalfy MA. Clinical outcome of carotid body paraganglioma management: a review of 10-year experience. J Oncol. 2020;2020:6081273.
Zhang W, Liu F, Hou K, et al. Surgical outcomes and factors associated with malignancy in carotid body tumors. J Vasc Surg. 2021;74:586-591.
Ma H, Wei M, Wang X, et al. Necessity of intraoperative level IIA lymph node dissection in patients with carotid body tumors: a retrospective study of 126 cases. ORL J Otorhinolaryngol Relat Spec. 2022;84:271-277.
Yang L, Li W, Zhang H, Yu L, Zheng M. Clinicopathological characteristics of patients with carotid body tumor with cervical lymph node metastasis. A retrospective study of 10 cases and review of the literature. Medicine. 2022;101:e30379.
Reitz K, Ramos A, Speranza G, et al. Non-functional carotid body tumors in patients without somatic mutations may be considered for non-operative management. Ann Vasc Surg. 2022;85:57-67.
Mayer R, Fruhwirth J, Beham A, Groell R, Poschauko J, Hackl A. Radiotherapy as adjunct to surgery for malignant carotid body paragangliomas presenting with lymph node metastases. Strahlenther Onkol. 2000;176:356-360.
Somasundar P, Krouse R, Hostetter R, Vaughan R, Covey T. Paragangliomas - A decade of clinical experience. J Surg Oncol. 2000;74:286-290.
Mall J, Saclarides T, Doolas A, Eibl-Eibesfeld B. First report of hepatic lobectomy for metastatic carotid body tumor. J Cardiovasc Surg (Torino). 2000;41:759-761.
Dias da Silva A, O'Donnell S, Gillespie D, Goff J, Shriver C, Rich N. Malignant carotid body tumor: a case report. J Vasc Surg. 2000;32:821-823.
van der Mey AGL, Jansen JC, van Baalen JM. Management of carotid body tumors. Otolaryngol Clin North Am. 2001;34:907-924.
Hinerman RW, Mendenhall WM, Amdur RJ, Stringer SP, Antonelli PJ, Cassisi NJ. Definitive radiotherapy in the management of chemodectomas arising in the temporal bone, carotid body, and glomus vagale. Head Neck. 2001;23:363-371.
Plukker JTM, Brongers EP, Vermey A, Krikke A, van den Dungen JJAM. Outcome of surgical treatment for carotid body paraganglioma. Br J Surg. 2001;88:1382-1386.
Bomanji JB, Hyder SW, Gaze MN, et al. Functional imaging as an aid to decision-making in metastatic paraganglioma. Br J Radiol. 2001;74:266-269.
Persky MS, Setton A, Niimi Y, Hartman J, Frank D, Berenstein A. Combined endovascular and surgical treatment of head and neck paragangliomas - a team approach. Head Neck. 2002;24:423-431.
Patetsios P, Gable DR, Garrett WV, et al. Management of carotid body paragangliomas and review of a 30-year experience. Ann Vasc Surg. 2002;16:331-338.
Kumaki N, Kajiwara H, Kameyama K, et al. Prediction of malignant behavior of pheochromocytomas and paragangliomas using immunohistochemical techniques. Endocr Pathol. 2002;13:149-156.
Lazaro B, Klemz M, Steiner Flores M, Landeiro JA. Malignant paraganglioma with vertebral metastasis. Arq Neuropsiquiatr. 2003;61:463-467.
Koch CA, Rodbard JS, Brouwers FM, Eisenhofer G, Pacak K. Hypotension in a woman with a metastatic dopamine-secreting carotid body tumor. Endocr Pract. 2003;9:310-314.
Argiris A, Mellott A, Spies S. PET scan assessment of chemotherapy response in metastatic paraganglioma. Am J Clin Oncol. 2003;26:563-566.
Niemann S, Muller U, Engelhardt D, Lohse P. Autosomal dominant malignant and catecholamine-producing paraganglioma caused by a splice donor site mutation in SDHC. Hum Genet. 2003;113:92-94.
Kohler HF, Carvalho AL, Mattos Granja NV, Nishinari K, Kowalski LP. Surgical treatment of paragangliomas of the carotid bifurcation: results of 36 patients. Head Neck. 2004;26:1058-1063.
Garcia Franco C, Heili S, Jimenez Hiscock L, Zapatero GJ. Pulmonary metastases in a bilateral carotid body paraganglioma. Interact Cardiovasc Thorac Surg. 2004;3:578-580.
Carroll W, Stenson K, Stringer S. Malignant carotid body tumor. Head Neck. 2004;26:301-306.
Uguz MZ, Arslanoglu S, Onal K, Gokce H. Malignant carotid body tumor: a case report. Kulak Burun Bogaz Ihtis Derg. 2004;13:38-40.
Benn DE, Gimenez-Roqueplo AP, Reilly JR, et al. Clinical presentation and penetrance of pheochromocytoma/paraganglioma syndromes. J Clin Endocrinol Metab. 2006;91:827-836.
Christie N, Parsons AM, Behrns KE. Metastatic hepatic paraganglioma 6 years after carotid body tumor resection. Clin Gastroenterol Hepatol. 2006;4:24.
Paris J, Facon F, Thomassin JM, Zanaret M. Cervical paragangliomas: neurovascular surgical risk and therapeutic management. Eur Arch Otorhinolaryngol. 2006;263:860-865.
Havekes B, Corssmit EPM, Jansen JC, van der Mey AGL, Vriends AHJT, Romijn JA. Malignant paragangliomas associated with mutations in the succinate dehydrogenase D gene. J Clin Endocrinol Metab. 2007;92:1245-1248.
Zheng JW, Zhong LP, Zhang ZY, et al. Carotid artery resection and reconstruction: clinical experience of 28 consecutive cases. Int J Oral Maxillofac Surg. 2007;36:514-521.
Zheng JW, Zhu HG, Yuan RT, et al. Recurrent malignant carotid body tumor: report of one case and review of the literature. Chin Med J (Engl). 2005;118:1929-1932.
Makeieff M, Raingeard I, Alric P, Bonafe A, Guerrier B, Marty-Ane C. Surgical management of carotid body tumors. Ann Surg Oncol. 2008;15:2180-2186.
van der Bogt KEA, Vrancken Peeters MPFM, van Baalen JM, Hamming JF. Resection of carotid body tumors. Results of an evolving surgical technique. Ann Surg. 2008;247:877-884.
Timmers HJLM, Pacak K, Bertherat J, et al. Mutations associated with succinate dehydrogenase D-related malignant paragangliomas. Clin Endocrinol (Oxf). 2008;68:561-566.
Rosa M, Sahoo S. Bilateral carotid body tumor: the role of fine-needle aspiration biopsy in the preoperative diagnosis. Diagn Cytopathol. 2008;36:178-180.
Kakkos SK, Reddy DJ, Shepard AD, Lin JC, Nypaver TJ, Weaver MR. Contemporary presentation and evolution of management of neck paragangliomas. J Vasc Surg. 2009;49:1365-1373.
Morton RP, Stewart T, Dray MS, Farmilo W. A role for ipsilateral, selective neck dissection in carotid body tumours. J Laryngol Otol. 2009;123:934-936.
Karaman E, Isildak H, Yilmaz M, et al. Management of paragangliomas in otolaryngology practice: review of a 7-year experience. J Craniofac Surg. 2009;20:1294-1297.
Ma D, Liu L, Yao H, et al. A retrospective study in management of carotid body tumour. Br J Oral Maxillofac Surg. 2009;47:461-465.
Li J, Wang S, Zee C, et al. Preoperative angiography and transarterial embolization in the management of carotid body tumor: a single-center, 10-year experience. Neurosurgery. 2010;67:941-948.
Lehmen JA, Babbel DM, Mikhitarian K, Choma TJ. Paraganglioma presenting as metastatic lesion in a cervical vertebra. A case report and review of the literature. Spine. 2010;35:E152-E154.
Kimura N, Tateno H, Saijo S, Horii A. Familial cervical paraganglioma with lymph node metastasis expressing somatostatin receptor type 2A. Endocr Pathol. 2010;21:139-143.
Ayala-Ramirez M, Callender GG, Kupferman ME, et al. Paraganglioma syndrome type 1 in a patient with Carney-Stratakis syndrome. Nat Rev Endocrinol. 2010;6:110-115.
Hall TC, Renwick P, Stafford ND. Recurrent familial malignant carotid body tumour presenting with lymph node metastasis: case report, and review of diagnosis and management of familial carotid body tumours. J Laryngol Otol. 2010;124:1344-1346.
Neskey DM, Hatoum G, Modh R, et al. Outcomes after surgical resection of head and neck paragangliomas: a review of 61 patients. Skull Base. 2011;21:171-176.
O'Neill S, O'Donnell M, Harkin D, Loughrey M, Lee B, Blair P. A 22-year Northern Irish experience of carotid body tumours. Ulster Med J. 2011;80:133-140.
Avgerinos ED, Moulakakis K, Brountzos E, et al. Advances in assessment and management of carotid body tumors. Vascular. 2011;19:250-256.
Liapis CD, Evangelidakis EL, Papavassiliou VG, Kakisis JD, Gougoulakis AG, Polyzos AK. Role of malignancy and preoperative embolization in the management of carotid body tumors. World J Surg. 2000;24:1526-1530.
Nishijima H, Asakage T, Sugasawa M. Malignant carotid body tumor with systemic metastases. Ann Otol Rhinol Laryngol. 2011;120:381-385.
Barraclough A, Bhamidipaty V, Bray P, Ponosh S. Carotid body tumour. ANZ J Surg. 2011;81:934-935.
Terzic A, Becker M, Wissmeyer M, Scolozzi P. 18F-DOPA PET/CT unravels malignant paraganglioma mimicking temporomandibular joint disorder. Dentomaxillofac Radiol. 2011;40:315-319.
Nazari I, Moghaddam FA, Zamani MM, Salimi J. Clinical characteristics and remedies in 45 Iranians with carotid body tumors. Acta Med Iran. 2012;50:339-343.
Williamson J, Leopold G, Prabhu V, Ingrams D. Successful treatment of a rare metastatic malignant carotid body tumour in a young adult, with conservative surgery and local radiotherapy. J Laryngol Otol. 2012;126:428-431.
Fruhmann J, Geigl JB, Konstantiniuk P, Cohnert TU. Paraganglioma of the carotid body: treatment strategy and SDH-gene mutations. Eur J Vasc Endovasc Surg. 2013;45:431-436.
Sen I, Stephen E, Malepathi K, Agarwal S, Shyamkumar NK, Mammen S. Neurological complications in carotid body tumors: a 6-year single-center experience. J Vasc Surg. 2013;57:64S-68S.
Luo T, Zhang C, Ning Y-C, Gu Y-Q, Li J-X, Wang Z-G. Surgical treatmernt of carotid body tumor: case report and literature review. J Geriatr Cardiol. 2013;10:116-118.
Moris D, Sotiropoulos G, Vernadakis S. Hepatic metastasis of a carotid body paraganglioma 5 years after resection of the primary tumor. Am Surg. 2013;79:E194-E196.
Serra R, Grande R, Gallelli L, et al. Carotid body paragangliomas and matrix metalloproteinases. Ann Vasc Surg. 2014;28:1665-1670.
Choi JDW, Tucker KM, Lee TT, Chong GC. Hereditary paraganglioma-pheochromocytoma syndromes associated with SDHD and RET mutations. Head Neck. 2014;36:E99-E102.
Gad A, Sayed A, Elwan H, et al. Carotid body tumors: a review of 25 year experience in diagnosis and management of 56 tumors. Ann Vasc Dis. 2014;7:292-299.
Peterson LA, Litzendorf M, Ringel MD, Vaccaro PS. SDHB gene mutation in a carotid body paraganglioma: case report and review of the paraganglioma syndromes. Ann Vasc Surg. 2014;28:1321.e9.
Oakes A, Witt B, Adler D. Metastatic carotid body paraganglioma detected during evaluation for biliary stone disease. Diagn Cytopathol. 2014;42:868-871.
Su HK, Urken ML, Khorsandi AS. Growing mass on the right side of the neck. JAMA Otolaryngol Head Neck Surg. 2014;140:1085-1086.
Gupta SK, Singla S, Karunanithi S, Damle N, Bal C. Peptide receptor radionuclide therapy with 177Lu DOTATE in a case of recurrent carotid body paraganglioma with spinal metastases. Clin Nucl Med. 2014;39:440-441.
Gilbo P, Tariq A, Morris CG, Mendenhall WM. External-beam radiation therapy for malignant paraganglioma of the head and neck. Am J Otolaryngol. 2015;36:692-696.
Leidenz FB, Bastos-Rodrigues L, Oliveira M, et al. Malignant phenotype and two SDHD mutations in a family with paraganglioma syndrome type 1. Genet Res (Camb). 2015;97:e3.
Anttila T, Hayry V, Nicoli T, et al. A two-decade experience of head and neck paragangliomas in a whole population-based single centre cohort. Eur Arch Otorhinolaryngol. 2015;272:2045-2053.
Xiao Z, She D, Cao D. Multiple paragangliomas of head and neck associated with hepatic paraganglioma: a case report. BMC Med Imaging. 2015;15:38.
Neychev V, Straughan D, Pacak K, Kebebew E. Multidisciplinary management of locally advanced and widely metastatic paraganglioma in a patient with life-threatening compressive symptoms. Head Neck. 2015;37:E205-E208.
Lamblin E, Atallah I, Reyt E, Schmerber S, Magne J-L, Righini CA. Neurovascular complications following carotid body paraganglioma resection. Eur Ann Otorhinolaryngol Head Neck Dis. 2016;133:319-324.
Mourad M, Saman M, Stroman D, Brown R, Ducic Y. Evaluating the role of embolization and carotid artery sacrifice and reconstruction in the management of carotid body tumors. Laryngoscope. 2016;126:2282-2287.
Davila VJ, Chang JM, Stone WM, et al. Current surgical management of carotid body tumors. J Vasc Surg. 2016;64:1703-1710.
Feyissa AM, Kenney-Jung DL, Shin C, Cheville JC, So EL. Clinical reasoning: an unusual cause of indeterminate spells. Neurology. 2016;87:e275-e280.
Smith JD, Harvey RN, Darr OA, et al. Head and neck paragangliomas: a two-decade institutional experience and algorithm for management. Laryngoscope Investig Otolaryngol. 2017;2:380-389.
Darouassi Y, Alaoui M, Mliha Touati M, et al. Carotid body tumors: a case series and review of the literature. Ann Vasc Surg. 2017;43:265-271.
Niemeijer ND, Rijken JA, Eijkelenkamp K, et al. The phenotype of SDHB germline mutation carriers: a nationwide study. Eur J Endocrinol. 2017;177:115-125.
Lopez A, Papouchado B, Brumund KT. Slowly growing right-sided neck mass with progressive dysphagia. JAMA Otolaryngol Head Neck Surg. 2017;143:419-420.
Tyagi R, Munjal M, Kaur P, Kaur H, Sood N. Parotid or carotid? Misled by site. Diagn Cytopathol. 2017;45:569-573.
Chen L, He S, Zhang Z, Liu D. Diagnostic pitfalls in fine-needle aspiration of metastatic carotid body paraganglioma: a case report. AJSP Rev Rep. 2017;22:225-229.
Hinojosa CA, Anaya-Ayala JE, Olivares-Cruz S, Laparra-Escareno H, Trolle-Silva A, Angeles-Angeles A. Malignant Shamblin III carotid body tumors resected with use of the retrocarotid dissection technique in 2 patients. Tex Heart Inst J. 2018;45:92-95.
Liu J, Li Y, Yang L, Cai H. Surgical resection of carotid body tumors with versus without preoperative embolization: retrospective case-control study. Head Neck. 2018;40:2590-2595.
Zhang J, Fan X, Zhen Y, et al. Impact of preoperative transarterial embolization of carotid body tumor: a single center retrospective cohort experience. Int J Surg. 2018;54:48-52.
Chmiel J, Loska P, Brzychczy A, et al. Carotid body paragangliomas - clinical variety and management (RCD code: I-O). J Rare Cardiovasc Dis. 2018;4:9-14.
McCrary H, Babajanian E, Calquin M, et al. Characterization of malignant head and neck paragangliomas at a single institution across multiple decades. JAMA Otolaryngol Head Neck Surg. 2019;145:641-646.
Bobadilla-Rosado LO, Garcia-Alva R, Anaya-Ayala JE, et al. Surgical management of bilateral carotid body tumors. Ann Vasc Surg. 2019;57:187-193.
Rijken JA, de Vos B, van Hest LP, et al. Evolving management strategies in head and neck paragangliomas: a single-centre experience with 147 patients over a 60-year period. Clin Otolaryngol. 2019;44:836-841.
Hassanein AG, Hassanein KA-AM, Fadle KN, Al-Eslam AS, Al Qahtani FN. The outcome of multidisciplinary management of carotid body tumors: retrospective cohort study. J Maxillofac Oral Surg. 2019;18:610-616.
Wang X, Zhu X, Chen J, Liu Y, Mao Q. Metastatic brain carotid body paraganglioma with endocrine activity: a case report and literature review. Br J Neurosurg. 2019;33:269-271.
Lin B, Yang H, Yang H, Shen S. A rare case of bilateral malignant paragangliomas. World Neurosurg. 2019;124:12-16.
Tripathy S, Damle NA, Naranje P, Shamim SA, Tripathi M, Bal C. Leptomeningeal metastasis in carotid body paraganglioma. Clin Nucl Med. 2019;44:e583-e585.
Amorosi NM, Dann A, White A. Case of a malignant carotid body tumor with systemic metastases: the utility of multimodal imaging. J Vasc Ultrasound. 2019;43:193-197.
Lozano FS, Munoz A, De Las Heras JA, Gonzalez-Porras JR. Simple and complex carotid paragangliomas. Three decades of experience and literature review. Head Neck. 2020;42:3538-3550.
Contrera KJ, Yong V, Reddy CA, Liu SW, Lorenz RR. Recurrence and progression of head and neck paragangliomas after treatment. Otolaryngol Head Neck Surg. 2020;162:504-511.
Li X, Zhang W, Shu C, Li Q, Zhang L, Zhu J. Diagnosis and outcomes of surgical treatment of carotid bifurcation tumors. J Int Med Res. 2020;48:1-12.
Sevil FC, Tort M, Kaygin MA. Carotid body tumor resection: long-term outcome of 67 cases without preoperative embolization. Ann Vasc Surg. 2020;67:200-207.
Kang J, Heo S-H, Park Y-J, Kim D-I, Kim Y-W. Differential diagnosis and treatment outcomes of tumors at the carotid bifurcation. Vasc Specialist Int. 2020;36:128-135.
Roll W, Muther M, Sporns PB, et al. Somatostatin receptor-targeted radioligand therapy in head and neck paraganglioma. World Neurosurg. 2020;143:E391-E399.
Han T, Wang S, Wei X, et al. Outcome of surgical treatment for carotid body tumors in different Shamblin type without preoperative embolization: a single-center retrospective study. Ann Vasc Surg. 2020;63:325-331.
Alshamsan B, Atallah JP. Durable response to Pazopanib in recurrent metastatic carotid body paraganglioma. Case Rep Oncol. 2020;13:1227-1231.
Xing J, Cheng Y, Ying H, Guan M, Jia N, Bai C. Systemic treatment of a metastatic carotid body tumor. A case report and literature review. Medicine (Baltimore). 2020;99:e22811.
Patchana T, Fan J, Jiganti M, Gnass RD. Metastatic acetabular fracture: a rare disease presentation of recurrent head and neck paraganglioma. Cureus. 2020;12:e7596.
Mohebali J, Edwards HA, Schwartz SI, Ergul EA, Deschler DG, LaMuraglia GM. Multispecialty surgical management of carotid body tumors in the modern era. J Vasc Surg. 2021;73:2036-2040.
Javidiparsijani S, Brickman A, Murro Lin D, et al. Is regional lymph node metastasis of head and neck paraganglioma a sign of aggressive clinical behavior: a clinical/pathologic review. Ear Nose Throat J. 2021;100:447-453.
Illuminati G, Pasqua R, Nardi P, Fratini C, Minni A, Calio FG. Results of resection of carotid body tumors with and without lymphnodes' dissection. Surg Oncol. 2021;37:101555.
Ding Y, Li L, Han D, Wang S, Chen X. Head and neck malignant paragangliomas: experience from a single institution. Ear Nose Throat J. 2021. doi:10.1177/01455613211052338
Yasan H, Kumbul YC, Ciris IM, Sivrice ME, Okur E. The importance of prostate-specific membrane antigen expression in carotid body paragangliomas. Turk Arch Otorhinolaryngol. 2021;59:203-209.
Basel H, Bozan N. Cervical paraganglioma: experience of 114 cases in 14 years. Braz J Otorhinolaryngol. 2021;87:127-131.
Greenberg SE, Holman R, Kohlmann W, Buchmann L, Naumer A. Paraganglioma and other tumour detection rates in individuals with SDHx pathogenic variants by age of diagnosis and after the age of 50. Clin Endocrinol (Oxf). 2021;95:447-452.
Tang H, Jiang X, Xue S, Fu W, Tang X, Guo D. Long-term surgical outcomes of carotid body tumors with pathological fibrosis: a cohort study. Front Oncol. 2021;11:684600.
Yamada H, Fukushima T, Kobayashi T, Kanda S, Koizumi T, Iwaya M. Successful response to cyclophosphamide, vincristine, and dacarbazine chemotherapy in a patient with metastatic carotid body paraganglioma. Case Rep Oncol. 2021;14:1827-1833.
Pavlov V, Snezhkina A, Kalinin D, et al. Case report: genetic alterations associated with the progression of carotid paraganglioma. Curr Issues Mol Biol. 2021;43:2266-2275.
Abolfotouh S, Back L, Aro K, et al. Carotid interposition in patients with head and neck tumors: clinical experience of 13 cases reconstructed with a great saphenous vein autograft. Acta Otolaryngol. 2022;142:419-424.
Tajibayev TK, Chormanov AT, Matkerimov AZ, et al. Carotid body tumors: case series of extremely rare head and neck paragangliomas. NAMJ. 2022;1:29-34.
Mikoshiba T, Yoshihama K, Ito F, et al. Carotid body tumor with neck metastasis due to germline SDHB variant: a case report and literature review. Int Cancer Conf J. 2021;11:6-11.
Jedrzejko N, Berg KB, Gurung A, MacKenzie S. Tumour to tumour metastasis: case of a carotid body paraganglioma metastatic to a hepatocellular adenoma. BMJ Case Rep. 2022;15:e248527.
Ihne S, Kircher M, Papagianni A, et al. AA amyloidosis in inflammatory active malignant paraganglioma. Amyloid. 2022;29:137-138.
Alfawaz A, Albloushi D, Quttaineh D, Alsafran S, AlQabandi O, Albader M. Malignant carotid body tumor: a report of two cases. Ann Med Surg. 2023;85:1857-1862.
Luna-Ortiz K, Bautista-Perez IJ, Luna-Peteuil Z, Martinez-Hernandez HJ. Carotid artery resection and reconstruction due to benign and malignant head and neck tumors. Indian J Otolaryngol Head Neck Surg. 2023;75:4216-4222.
Tabb JN, Maas JA, Earla BP, Fallon KB, McDonald AM, Dobelbower MC. Carotid body paraganglioma metastatic to spine causing cord compression: a case report. Diagn Pathol. 2023;18:31.
Munn Z, Barker TH, Moola S, et al. Methodological quality of case series studies: an introduction to the JBI critical appraisal tool. JBI Evid Synth. 2020;18:2127-2133.
DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177-188.
Higgins JPT, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21:1539-1558.
Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003;327:557-560.
Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629-634.
Mottie L, Meulemans J, Vander Poorten V. Vagal paragangliomas. Curr Opin Otolaryngol Head Neck Surg. 2023;31:146-154.
Lee JH, Barich F, Hynds Karnell L, et al. National Cancer Data Base report on malignant paragangliomas of the head and neck. Cancer. 2002;94:730-737.
Astuti D, Latif F, Dallol A, et al. Gene mutations in the succinate dehydrogenase subunit II SDHB cause susceptibility to familial pheochromocytoma and to familial paraganglioma. Am J Hum Genet. 2001;69:49-54.
Baysal BE, Ferrell RE, Willett-Brozick JE, et al. Mutations in SDHD, a mitochondrial complex II gene, in hereditary paraganglioma. Science. 2000;287:848-851.
Por YC, Lim DTH, Teoh MK, Soo KC. Surgical management and outcome of carotid body tumours. Ann Acad Med Singapore. 2002;31:141-144.
Ahuja A, Kumari S. A rare case of malignant metastatic tumor diagnosed on fine-needle aspiration of cervical lymph node. Cytojournal. 2019;16:15.
Harley RJ, Lee JH, Ostrander BT, et al. Local tumor behavior associated with survival among patients with paraganglioma of the head and neck. OTO Open. 2022;6:1-12.
Lloyd RV, Osamura RY, Kloppel G, Rosai J, eds. WHO Classification of Tumours of Endocrine Organs. IARC Press; 2017.
Amar L, Pacak K, Steichen O, et al. International consensus on initial screening and follow-up of asymptomatic SDHx mutation carriers. Nat Rev Endocrinol. 2021;17:435-444.
Taieb D, Wanna GB, Ahmad M, et al. Clinical consensus guideline on the management of phaeochromocytoma and paraganglioma in patients harbouring germline SDHD pathogenic variants. Lancet Diabetes Endocrinol. 2023;11:345-361.
Kajal S, Kairo AK, Quadri JA, et al. Can superoxide anions predict the malignant potential of carotid body tumor? A pilot study. Indian J Otolaryngol Head Neck Surg. 2023;75:1819-1825.
Zbaren P, Lehmann W. Carotid paraganglioma with metastases. Laryngoscope. 1985;95:450-454.
Netterville JL, Reilly KM, Robertson D, Reiber ME, Armstrong WB, Childs P. Carotid body tumors: a review of 30 patients with 46 tumours. Laryngoscope. 1995;105:115-126.
Naswa N, Kumar A, Sharma P, Bal C, Malhotra A, Kumar R. Imaging carotid body chemodectomas with 68Ga-DOTA-NOC PET-CT. Br J Radiol. 2012;85:1140-1145.
Plouin P-F, Fitzgerald P, Rich T, et al. Metastatic pheochromocytoma and paraganglioma: focus on therapeutics. Horm Metab Res. 2012;44:390-399.
Niemeijer ND, Alblas G, Van Hulsteijn LT, Dekkers OM, Corssmit EPM. Chemotherapy with cyclophosphamide, vincristine and dacarbazine for malignant paraganglioma and pheochromocytoma: systematic review and meta-analysis. Clin Endocrinol (Oxf). 2014;81:642-651.
Joshua AM, Ezzat S, Asa SL, et al. Rationale and evidence for sutinib in the treatment of malignant paraganglioma/pheochromocytoma. J Clin Endocrinol Metab. 2009;94:5-9.
O'Kane GM, Ezzat S, Joshua AM, et al. A phase 2 trial of sunitinib in patients with progressive paraganglioma or pheochromocytoma: the SNIPP trial. Br J Cancer. 2019;120:1113-1119.
Goffredo P, Sosa JA, Roman SA. Malignant pheochromocytoma and paraganglioma: a population level analysis of long-term survival over two decades. J Surg Oncol. 2013;107:659-664.
Fitzgerald PA, Goldsby RE, Huberty JP, et al. Malignant pheochromocytomas and paragangliomas: a phase II study of therapy with high-dose 131I-metaiodobenzylguanidine (131I-MIBG). Ann N Y Acad Sci. 2006;1073:465-490.